New peptide injection could get athletes back in the game faster
NCT ID NCT07437547
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a daily injection of BPC 157, a synthetic peptide, can help people with a moderate hamstring tear heal faster. 120 adults aged 18-45 with a recent MRI-confirmed grade II strain will receive either BPC 157 or a placebo for 14 days, plus standard rehab. The main goals are to see how quickly they can return to sport and how much the muscle injury shrinks on MRI.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BPC 157 (a synthetic peptide given as a daily injection for 14 days)
- What this could lead to
- If it works, this could provide a new treatment to help athletes and active people recover faster from hamstring injuries.
- What could go wrong
- This is an early Phase 2 trial with only 120 people, so results may not apply to everyone. The peptide is investigational and its safety and effectiveness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAMSTRING MUSCLE STRAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518036, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.